Introduction
The human CYP2C subfamily consists of four members, namely CYP2C18, CYP2C19, CYP2C9 and CYP2C8, and accounts for the biotransformation of 20-30% of all drugs prescribed worldwide. The encoding genes are located in tandem on chromosome 10q23-24 and those most important for drug metabolism, namely CYP2C8, CYP2C9 and CYP2C19 are highly polymorphic (http://www.cypalleles. ki.se). Importantly, polymorphisms in these genes have been associated with clinically relevant consequences in drug pharmacokinetics, efficacy and/or toxicity. Distinct examples, affecting drugs widely used in Brazil include the influence of CYP2C9*2, *3, *5 and *8 polymorphisms on warfarin dosing requirements, [1] [2] [3] the association of CYP2C19*2 and *3 low-activity alleles with clinical efficacy of clopidogrel and proton pump inhibitors, [4] [5] [6] and the impact of CYP2C8*2 and *3 variants on the pharmacokinetics of taxanes and the antimalarial amodiaquine. [7] [8] [9] The frequency of CYP2C polymorphisms varies markedly among populations, a notable example being the CYP2C19*17 gainof-function polymorphism, which occurs in ca. 20% of Europeans and sub-Saharan African populations but is less common (2-4%) in Asian populations. 10, 11 Distinct interethnic differences in allele frequency are observed in other functional CYP2C polymorphisms, such as CYP2C8*2, CYP2C8*3, CYP2C9*3, CYP2C19*2 and CYP2C19*3.
12-14
Furthermore, statistically significant differences in the prevalence of CYP2C polymorphisms occur within continental populations, as for example, CYP2C8*3, CYP2C9*2 and CYP2C9*3 among Europeans.
14 Previous data from one of our labs 15 revealed yet another level of population diversity in the prevalence of CYP2C polymorphisms; among Brazilians from Rio de Janeiro, the frequency of CYP2C9*2 and CYP2C9*3 differs significantly across the 'race/color' categories adopted by the Brazilian Census. This result is not surprising, in view of the heterogeneity and extensive admixture of the present-day Brazilian population, in which the European, African and Amerindian components of genomic ancestry vary extensively and, most importantly, in a continuous manner. 16, 17 This study examines the frequency distribution of 10 functional CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a large sample of healthy Brazilians recruited at four geographical regions, and correlates these frequency data with the individual proportions of European, African and Amerindian biogeographical ancestry, estimated with a panel of ancestryinformation markers. 18 
Methods
The study protocol was approved by the Ethics Committees of the Instituto Nacional de Câncer, Rio de Janeiro, where the CYP2C polymorphisms were genotyped, and by the Ethics Committees of the institutions, which participated in the collection of blood samples for DNA extraction.
Study population
The study cohort consisted of 1034 healthy, unrelated adults recruited in the North, Northeast, Southeast and South regions of Brazil (Supplementary Figure 1) , in the context of a project designed to genotype a panel of pharmacogenetic polymorphisms in the Brazilian population. Each individual signed a written informed consent and was asked to selfidentify according to the classification scheme adopted by the Brazilian Census (http://www.ibge.gov.br), which relies on self-perception of skin color. Accordingly, the subjects were distributed in three groups: branco (White, n ¼ 342), pardo (Brown, n ¼ 350) and preto (Black, n ¼ 342). The term Color will be capitalized heretofore to call attention to its special meaning in the context of the Brazilian Census classification. This study cohort is considered representative of the present-day Brazilian population as 99% of Brazilians self-identify in one of the three Color categories, and 93% live in one of the four regions, included in the study (http:// www.sidra.ibge.gov.br/bda/tabela/listabl.asp?z ¼ t&c ¼ 262). Individuals from the Center West region (7% of the Brazilian population) and those who self-identify as 'Yellow' (meaning Asian descendants, 0.7%) or Amerindian (0.3%) were not included in this study. Table 1 lists the 10 single nucleotide polymorphisms (SNPs) in CYP2C8, CYP2C9 and CYP2C19, which were genotyped. Allele discrimination at each locus was performed on a Fast 7500 Real-Time System (Applied Biosystems, Foster City, CA, USA) using TaqMan assays purchased from Applied Biosystems, following the manufacturer's protocols, with reaction volumes reduced to 7 ml. Calculation and visualization of pairwise linkage disequilibrium (D') between the SNPs were carried out using the software Haploview version 4.1 (see ref. 19 ). Individual diplotypes were inferred using the haplo-stats software, version 1.3, available at http://mayoresearch.mayo. edu/mayo/research/schaid_lab/software.cfm. This software attributes a posterior probability value for the diplotype configuration for each individual on the basis of estimated haplotype frequencies. The minimal posterior probability value for inclusion of an individual in these analyses was set at 0.94. The sequence of the SNPs in the haplotypes is indicated in Table 1 . Haplotypes are labeled by numbers (1) (2) (3) (4) (5) (6) (7) (8) , preceded by 'Br', a reference to this Brazilian cohort.
CYP2C alleles and haplotypes

Statistical analyses
Allele frequency of the CYP2C polymorphisms was derived by gene counting. We infer the statistical association between the CYP2C alleles and haplotypes among Brazilians (response variables), and ancestry, self-reported Color and geographical region (explanatory variables) by fitting multinomial log-linear models via neural networks. 20 The covariate ancestry entered the model transformed as a piecewise polynomial term allowing for nonlinear contributions, and the result of the model-fitting exercise is presented as suggested by Fox, 21 in graphic format relating the proportion of individuals with the variant marker against the proportion of ancestry in a cluster specified by the software STRUCTURE (available at http://pritch.bsd. uchicago.edu/software/structure2_1.html). 22 This method, described by Venables and Ripley 20 is implemented as function 'multinom' available in the R package 'nnet'. 23 Contribution of model components are tested by comparing the deviance of subset models and by the AIC statistics. A P-value o0.05 was considered significant.
Results
We initially report data for the overall study cohort, and show in Table 2 the frequency of the 10 variant alleles interrogated in the CYP2C gene cluster. CYP2C19*3 was detected in only one individual in heterozygosity, whereas CYP2C9*5 and CYP2C9*11 were rare alleles (o1%). The frequency of the other variants ranged from 3.4 (CYP2C8*4) to 17.3% (CYP2C19*17). Two distinct haplotype blocks were identified using the 'Four gamete of LD' method in Haploview ( Figure 1 ): block 1 consists of three SNPs (rs12248560, rs4244285 and rs1799853) corresponding to CYP2C19*17, CYP2C19*2 and CYP2C9*2, respectively, and block 2 consists of six markers (rs28371685, rs1057910, rs28371686, rs11572103, rs1058930 and rs11572080) corresponding to CYP2C9*11, CYP2C9*3, CYP2C9*5, CYP2C8*2, CYP2C8*4 and CYP2C8*3, respectively. Diplotype analysis generated 41 haplotypes, of which eight had frequencies greater than 1% and together accounted for 96.4% of the overall genetic diversity in the study cohort ( Figure 2 ). The gain-of-function CYP2C19*17 variant allele was found alone on Hap Br3 (11.5%) and together with the decreased function CYP2C8*2 allele in Hap Br5 (5.6%). The loss-of-function CYP2C19*2 allele was found alone in Hap Br2 (11.5%) and the decreased function alleles CYP2C9*3, CYP2C8*4 and CYP2C9*2 were found alone in Hap Br6 (3.6%), Hap Br8 (1.4%) and Hap Br7 (1.5%), respectively. However, CYP2C9*2 was more frequently found in LD with CYP2C8*3 in Hap Br4 (7.3%), as previously reported for other populations.
14,24
Distribution of CYP2C polymorphisms among Brazilians according to ancestry These analyses were on the basis of individual proportions of European, African and Amerindian ancestry, estimated using a panel of short insertion/deletion polymorphisms (indels), validated as ancestry informative markers 18 and the STRUCTURE clustering software. These data, available for 965 subjects (93% of the study cohort) 25 reveal that the vast Amerindian ancestry was relatively constant across the three Color groups, ranging from 0.10 to 0.13. We explored the association between biogeographical ancestry and distribution of CYP2C alleles and haplotypes by fitting multinomial log-linear models to the individual genomic ancestry (Methods). The results, presented in graphic format show that the individual odds of having alleles CYP2C8*3, CYP2C9*2 and CYP2C9*3 increase, whereas the odds of having the CYP2C8*2 allele decrease continuously as the proportion of European ancestry increases ( Figure 4 ). A pattern of continuous variation as a function of European ancestry proportions is also evident in the distribution of haplotype probabilities ( Figure 5 ). The most distinct variations are the increasing odds of having Hap Br3 and Hap Br4, and decreasing odds of having Hap Br5 as the proportion of European ancestry increases. As a second approach to explore the association between biogeographical ancestry and distribution of CYP2C polymorphisms, we arbitrarily created three categories (A, B and C) according to individual proportions of European or African ancestry (Table 3) : category A: 40.8 (80%) African ancestry, category B: 0.4-0.6 European ancestry and category C: 40.9 European ancestry. We wish to emphasize that categories A, B and C have no equivalent in the self-reported Color classification adopted by the Brazilian Census. This is evident from Table 3 , which shows that among the 256 individuals in category C (40.9 European ancestry), 30 selfidentified as Black and 66 as Brown. Significant differences were observed in the frequency distribution of CYP2C8 (Po0.0001) and CYP2C9 (P ¼ 0.0006) variant alleles, whereas no difference occurred with respect to CYP2C19 polymorphisms (P ¼ 0.59; Table 3 ). These results reflect the trends for decreasing frequency of CYP2C8*2, CYP2C9*5 and CYP2C9*11, and increasing frequency of CYP2C8*3, CYP2C8*4, CYP2C9*2 and CYP2C9*3 as the proportion of African ancestry decreases, and European ancestry increases from categories A to C. The frequencies of CYP2C8*3 and CYP2C9*2 in each category were highly correlated (R 2 ¼ 0.99; ratio of frequencies 0.89 ± 0.13), in agreement with the strong LD between these two SNPs in the overall cohort (D' ¼ 0.86, Figure 1 ). The distribution of CYP2C haplotypes also differed significantly across categories A, B and C (Po0.0001), reflecting the increasing frequency of Hap Br4 and Hap Br6, and the decreasing frequency of Hap Br5 from categories A to B and then to C. Table 4 displays the allele distribution of the CYP2C polymorphisms among Brazilians, stratified by geographical region and self-reported Color (12 groups). The frequency of the CYP2C8*3 and CYP2C9*2 in the 12 groups defined by Color and region were highly correlated (R 2 ¼ 0.95; ratio of frequencies 0.89±0.11), as anticipated from the strong LD between these two polymorphisms (see above). Multinomial log-linear regression analyses (Table 5) showed that geographical region per se has no significant effect on the frequency distribution of the CYP2C8, CYP2C9 or CYP219 variant alleles. By contrast, Color per se or in combination with geographical region, was significantly associated with the frequency distribution of the CYP2C8 and CYP2C9 variant alleles, whereas no association was observed with respect to the CYP2C19 alleles. The significant associations reflect the trends for decreasing frequency of CYP2C8*3, CYP2C9*2 and CYP2C9*3, and increasing frequency of CYP2C8*2, from White, to Brown and then to Black individuals in some, but not all geographical regions.
Distribution of CYP2C polymorphisms among Brazilians according to Color categories and geographical regions
The distribution of the CYP2C haplotypes among the 12 groups defined by Color and geographical region are shown in Table 6 . Multinominal log-linear regression analysis revealed significant effects of Color per se (Po0.0001), and Color combined with geographical region (P ¼ 0.002) on the distribution of the CYP2C haplotypes among Brazilians. Effect display for the distribution of CYP2C polymorphisms in the logit model fit to the data for European ancestry in 965 Brazilians. The individual proportion of European ancestry is shown in the x-axis. The y-axis is labeled on the probability scale. This graphic is produced as described in the Methods section.
Global pharmacogenomics of the CYP2C cluster G Suarez-Kurtz et al Geographical region per se was not associated with the distribution of the CYP2C haplotypes.
Discussion
Previous pharmacogenetic studies of the CYP2C cluster in Brazilians were restricted to CYP2C9 in individuals from the Southeast region, 1, 15, 26 and the reported frequencies of the CYP2C9*2, *3, *5 and *11 alleles are in excellent agreement with the present results for the same region. We now report the first large-scale study of the distribution of functional polymorphisms in the CYP2C cluster in a representative cohort of the present-day Brazilian population. One major conclusion that emerges from this study is that the heterogeneity and diversity of the Brazilian population 25, 27, 28 is reflected in the distribution of functional polymorphisms in the CYP2C cluster. Specifically, the frequency of CYP2C8 and CYP2C9 alleles and CYP2C haplotypes varies within self-reported Color groups, across Hap Br1 Haplotype probability Proportion of European ancestry Figure 5 Effect display for the distribution of CYP2C haplotypes in the logit model fit to the data for European ancestry in 927 Brazilians. The individual proportion of European ancestry is shown in the x-axis. The y-axis is labeled on the probability scale. This graphic is produced as described in the Methods section. One-way ANOVA.
Global pharmacogenomics of the CYP2C cluster G Suarez-Kurtz et al Table 4 Allele frequency of CYP2C polymorphisms in Brazilians according to self-reported Color and geographical region Brazilians have a tri-hybrid ancestral background, with Amerindian, European and African roots, and a history of extensive interethnic mating over several centuries. The resulting genetic admixture is evident in the distribution of the individual proportions of Amerindian, European and African ancestry in the study cohort ( Figure 3) . A full account of the results obtained with ancestry informative markers in this cohort is in preparation (Pena et al.) . 24 In this study, we highlight two features that are particularly relevant to the interpretation of the present data on CYP2C polymorphisms: First, the European and African components together account for 89% of the diversity in individual genetic ancestry and, consequently, will have a considerably greater impact on the frequency of CYP2C polymorphisms, as compared with Amerindian ancestry. Second, the individual proportions of European and African ancestry vary over wide ranges, and most importantly, as a continuum, irrespective of self-reported Color and geographical origin. On the basis of these two features, it is reasonable to anticipate (i) that the greater the difference in frequency of a given CYP2C allele between European and sub-Saharan African ancestral populations, the more likely the allele frequency will vary within the admixed Brazilian population, and (ii) that CYP2C allele frequency will vary continuously, as a function of the individual proportions of European and/or African ancestry. We confirmed these predictions using as proxi of ancestral populations, the Portuguese, by far the most important source of European migrants from Brazil, and sub-Saharan Africans from former Portuguese colonies, origin of enslaved Africans brought to Brazil. Thus, alleles that differ markedly in frequency between Portuguese 29,30 vs Mozambicans and/or Angolans, 31 ,32 such as CYP2C8*2 (1.2 vs 16.2%), CYP2C8*3 (19.8 vs 0%), CYP2C9*2 (13.2 vs 0%) and CYP2C9*3 (8.0 vs 0.5%) were found at significantly different frequencies in Brazilians included in categories A, B and C, defined by ranges of European and African ancestry. Accordingly, haplotypes including CYP2C8*2 (Hap Br5), CYP2C9*3 (Hap Br6) and both CYP2C8*3 and CYP2C9*2 (Hap Br4) differed markedly in frequency across categories A, B and C.
Log-linear regression modeling allowed extension of these results to the entire cohort, and verified that the distribution of CYP2C8 and CYP2C9 alleles, and of the CYP2C haplotypes can be modeled by continuous functions of the individual proportions of European ancestry, irrespective of self-reported Color or geographical origin. As a corollary, the significant association between Color, per se or combined with geographical region, and distribution of CYP2C polymorphisms may be ascribed to differences in genetic ancestry across self-reported Color groups in the geographical regions examined. There is evidence that these differences exist in the study cohort. Thus, Pena et al. 25 observed an 'exuberant diversity in the ancestral Amerindian, European and African proportions of the different color categories, both between and within the different regions', leading to the conclusion that 'people who are White, Brown or Black in the northern part of Brazil are ancestrally quite unlike people who are White, Brown or Black in the southern part of the Country'. We propose that these features account for the differences in the distribution of CYP2C polymorphisms and haplotypes among Color groups in different regions of Brazil, observed in this study. It follows that Color categories are, at best, poor proxies of biogeographical ancestry in Brazilians.
From a pharmacogenomics perspective, this study leads to two important conclusions: first, it makes little sense to extrapolate data on CYP2C8 and CYP2C9 polymorphisms or CYP2C haplotypes from one or more Color strata recruited at a given region (or city) to the ensemble of Brazilians. Second, the intrinsic heterogeneity of the Brazilian population must be acknowledged in the design and interpretation of pharmacogenomic studies of the CYP2C cluster in order to avoid spurious conclusions based on improper matching of study cohorts. Both these conclusions may be extended to other pharmacogenes, as recently shown for VKORC1 polymorphisms, 33 which are the most important predictors of warfarin dose requirement in Brazilians. 1 CYP2C9 and CYP2C8 are major drug-metabolizing enzymes for several therapeutic groups and the functional polymorphisms interrogated in this study have distinct pharmacokinetic and/or pharmacodynamic consequences (Introduction). Our results show that prediction of adverse effects or therapeutic efficacy based on 'race' (Color, in our study) or average proportions of genetic ancestry in 'race' categories is clearly inappropriate in the case of Brazilians. Most likely, this conclusion applies to other admixed populations of the Americas. Global pharmacogenomics of the CYP2C cluster G Suarez-Kurtz et al
